Clin2
NCT06113224Possibly a fitNot yet recruiting

Immune response after donated heart valve replacement

Lung Graft Dysfunction

Part of Immune system & allergy, Lungs & breathing clinical trials.

This study looks at how your immune system reacts to a donated heart valve (called a homograft) used to replace your pulmonary valve. It will help doctors understand why some people develop antibodies that might affect the valve, which could improve future care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
53 people
Ages
14 years and older
Study type
Interventional

Who can take part

  • You must be 14 years or older.
  • You must be scheduled to receive a pulmonary valve replacement using a donated valve (homograft).
  • You cannot have had a blood transfusion during your surgery or within the last 6 months.
  • You cannot have had any HLA antibodies (immune proteins that might attack the donor valve) before this surgery.
  • You cannot be pregnant or have given birth in the last 6 months.
  • Your surgery must be planned (not an emergency), and you (or your parents/guardians) must sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02423070Recruiting
Study how donor genetic material behaves after lung or heart transplant

This study looks at how transplanted genetic material (DNA) changes and settles in the body after lung or heart transplant. It may help doctors understand transplant healing and improve future care for transplant recipients and candidates.

Phoenix, Arizona
NCT06387446Recruiting
Donated heart valve transplant for children and young adults

This study is testing a new way to replace a damaged heart valve using a donated valve (allograft) that may last longer and work better for children and young adults. It may be a good option if you need a new valve and have few other choices.

Boston, Massachusetts
NCT05809856Recruiting
Check if a patient’s own valve tissue can be safely used

This study tests whether a new type of heart valve made from your own tissue (an “autologous” valve) can be placed through a catheter safely in adults with leaking and pressure-related problems in the lung heart valve area. If it works well, it could offer a safer option for people who need treatment for pulmonary valve problems.

Berlin, State of Berlin
NCT05452720Recruiting
Testing a new pulmonary valve replacement in children

This study tests an early, first-use version of a new pulmonary valve device for children whose own valve is not working well. It may help improve blood flow from the heart to the lungs and aims to learn how safe and effective the valve is over time.

Peoria, Illinois
NCT07865533Not yet recruiting
Immune response and lung health after heart surgery

This study looks at how your immune system responds after heart surgery and whether it affects lung complications. It may help doctors find ways to prevent breathing problems after surgery.

Paris
NCT04837339Recruiting
Testing markers to predict problems after lung transplant

This study looks for lab “clues” that can help predict how well someone’s lungs will do after a lung transplant. It may help doctors spot transplant-related problems earlier so care can be planned sooner.

Suresnes

Hear when a new Lung Graft Dysfunction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.